Intraoral radiation stents—Primer for clinical use in head and neck cancer therapy

Head & Neck ◽  
2021 ◽  
Author(s):  
Annu Singh ◽  
Evan B. Rosen ◽  
Joseph D. Randazzo ◽  
Cherry L. Estilo ◽  
Daphna Y. Gelblum ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Clinical Use

scholarly journals Satisfaction survey of pain management for severe mucositis caused by cancer therapy for head and neck cancer

2012 ◽  
Vol 7 (2) ◽  
pp. 408-414 ◽  
Author(s):  
Naomi Mizukami ◽  
Masanori Yamauchi ◽  
Akihiko Watanabe ◽  
Keiko Danzuka ◽  
Akemi Satoh ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Pain Management ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Satisfaction Survey ◽  
Severe Mucositis

Patient-Reported Outcomes Integrated Within an Electronic Medical Record in Patients With Head and Neck Cancer

2021 ◽  
pp. 842-848
Author(s):  
Stephanie Ossowski ◽  
Amy Kammerer ◽  
Douglas Stram ◽  
Lisa Piazza-DeLap ◽  
Ethan Basch ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Medical Record ◽  
Electronic Medical Record ◽  
Neck Cancer ◽  
Functional Assessment ◽  
Primary Language ◽  
Patient Reported ◽  
Pro Tools

PURPOSE Patient-reported outcome (PRO) tools lead to clinical benefits, including improved overall survival for patients with cancer. However, routine implementation of PROs in clinical practice within the electronic medical record (EMR) by integrated health care delivery systems remains limited. We studied the use of a PRO tool for patients with head and neck cancer (HNC) integrated in an EMR at Kaiser Permanente in Northern California. METHODS Between August 2017 and December 2019, patients with newly diagnosed HNC were surveyed at baseline, then every 3 months using the Functional Assessment of Cancer Therapy–General 7 and Functional Assessment of Cancer Therapy–Head and Neck (version 4). A medical assistant performed a baseline survey on diagnosis and then notified patients electronically per surveillance protocol. Patients who did not respond to online PRO surveys could complete them via telephone or in-person appointments with medical assistants. Abnormal findings on PRO surveys were referred to appropriate members of the care team or the treating Otolaryngology-Head and Neck Surgery physicians. RESULTS Two hundred ninety patients received baseline surveys. Patients received up to a maximum of eight subsequent surveys. Of a total of 597 electronic surveys, 585 (97.9%) were completed. The percentage of patients completing each interval survey ranged from 92% to 100%. Multivariate Poisson regression analysis showed patients with English as their primary language and an online secure account were the most likely to complete surveys compared with those patients with non-English as a primary language and without an online account. CONCLUSION PRO tools can be effectively used within the EMR for patients with HNC with a high response rate provided there is strong engagement from a dedicated member of the care team. This has important implications for designing clinical trials and symptom monitoring in clinical practices that incorporate EMRs.

Oral examination findings, taste and smell testing during and following head and neck cancer therapy

2020 ◽  
Vol 28 (9) ◽  
pp. 4305-4311 ◽  
Author(s):  
Joel B. Epstein ◽  
Dana Villines ◽  
Geena L. Epstein ◽  
Gregory Smutzer
Keyword(s):  
Head And Neck Cancer ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Oral Examination ◽  
Taste And Smell

Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents

2006 ◽  
Vol 18 (3) ◽  
pp. 247-252 ◽  
Author(s):  
Francesco Caponigro ◽  
Amalia Milano ◽  
Maria Basile ◽  
Franco Ionna ◽  
Rosario Vincenzo Iaffaioli
Keyword(s):  
Head And Neck Cancer ◽  
Cancer Therapy ◽  
Head And Neck ◽  
Neck Cancer ◽  
Targeted Agents ◽  
Recent Advances ◽  
Molecular Targeted Agents
Sign in / Sign up

Export Citation Format

Share Document